Implementation of a novel vocal cord dysfunction management pathway using the consolidated framework for

Greg Merlo1, Jessica M Suna2,3, Amy McIntosh2

  • 1Primary Care Clinical Unit, The University of Queensland, Brisbane, Australia.

Insights

Implementing a new vocal cord dysfunction (VCD) management pathway for children with congenital heart disease in Australia proved feasible. This structured approach aims to safely transition children to oral feeding post-surgery.

Area of Science:

  • Pediatric Surgery
  • Cardiology
  • Speech Pathology
  • Implementation Science

Background:

  • Congenital heart disease (CHD) affects over a thousand Australian children annually, often requiring surgical intervention.
  • Vocal cord dysfunction (VCD) is a significant postoperative complication following CHD surgery, impacting patient outcomes.
  • Multidisciplinary care pathways are crucial for optimizing clinical care and reducing mortality/morbidity in complex pediatric cases.

Purpose of the Study:

  • To implement and evaluate a novel, multidisciplinary management pathway for children experiencing postoperative VCD.
  • To facilitate the safe commencement and transition to oral feeding for pediatric patients with VCD.
  • To assess the feasibility and identify barriers/facilitators to pathway adoption in a clinical setting using the CFIR framework.

Main Methods:

  • An implementation study utilizing the Consolidated Framework for Implementation Research (CFIR).
  • Pathway rollout involved education sessions for clinical stakeholders and adaptations for consent and patient identification.
  • A dedicated team was assigned for ongoing patient monitoring post-recruitment.
  • Implementation success was measured by compliance with the pathway's defined management protocols.

Main Results:

  • Despite several barriers encountered during adoption, the implementation of the VCD management pathway was found to be feasible.
  • Adaptations to the pathway were necessary, particularly in response to the challenges posed by the COVID-19 pandemic.
  • Compliance with pathway-defined management served as the primary metric for evaluating implementation success.

Conclusions:

  • The developed multidisciplinary pathway is a feasible approach for managing postoperative VCD in children undergoing CHD surgery.
  • Pathway adaptations are critical for successful implementation in dynamic healthcare environments, as demonstrated during the COVID-19 pandemic.
  • Continued refinement and adherence to structured pathways can improve the transition to oral feeding and overall patient outcomes.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.5K
Nursing Implementation01:15

Nursing Implementation

Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
5.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
265
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
80
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
81